Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2016 Apr;27(4):1254-64.
doi: 10.1681/ASN.2015010068. Epub 2015 Oct 9.

Serum Indoxyl Sulfate Associates with Postangioplasty Thrombosis of Dialysis Grafts

Affiliations
Observational Study

Serum Indoxyl Sulfate Associates with Postangioplasty Thrombosis of Dialysis Grafts

Chih-Cheng Wu et al. J Am Soc Nephrol. 2016 Apr.

Abstract

Hemodialysis vascular accesses are prone to recurrent stenosis and thrombosis after endovascular interventions.In vitro data suggest that indoxyl sulfate, a protein-bound uremic toxin, may induce vascular dysfunction and thrombosis. However, there is no clinical evidence regarding the role of indoxyl sulfate in hemodialysis vascular access. From January 2010 to June 2013, we prospectively enrolled patients undergoing angioplasty for dialysis access dysfunction. Patients were stratified into tertiles by baseline serum indoxyl sulfate levels. Study participants received clinical follow-up at 6-month intervals until June 2014. Primary end points were restenosis, thrombosis, and failure of vascular access. Median follow-up duration was 32 months. Of the 306 patients enrolled, 262 (86%) had symptomatic restenosis, 153 (50%) had access thrombosis, and 25 (8%) had access failure. In patients with graft access, free indoxyl sulfate tertiles showed a negative association with thrombosis-free patency (thrombosis-free patency rates of 54%, 38%, and 26% for low, middle, and high tertiles, respectively;P=0.001). Patients with graft thrombosis had higher free and total indoxyl sulfate levels. Using multivariate Cox regression analysis, graft thrombosis was independently predicted by absolute levels of free indoxyl sulfate (hazard ratio=1.14;P=0.01) and free indoxyl sulfate tertiles (high versus low, hazard ratio=2.41;P=0.001). Results of this study provide translational evidence that serum indoxyl sulfate is a novel risk factor for dialysis graft thrombosis after endovascular interventions.

Keywords: arteriovenous shunt; hemodialysis access; thrombosis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Kaplan–Meier curves of access patency. (A) Restenosis-free patency and (B) thrombosis-free patency stratified by the tertiles of baseline free indoxyl sulfate levels. P values were tested by log-rank test. H, high; L, low; M, middle.
Figure 2.
Figure 2.
Kaplan–Meier curves of thrombosis-free patency by groups. (A) Graft access, (B) native access, (C) nondiabetic patients, and (D) diabetic patients stratified by the tertiles of baseline free indoxyl sulfate levels. P values were tested by log-rank test. H, high; L, low; M, middle; PTA, percutaneous transluminal angioplasty.
Figure 3.
Figure 3.
Comparisons of indoxyl sulfate levels between patients with and without access thrombosis. (A and B) All participants, (C and D) stratified by diabetes or nondiabetes, and (E and F) stratified by graft or native accesses. Upper row (A, C, and E): free form; and lower row (B, D, and F): total form. Whisker plots show the 10th, 25th, 50th, 75th, and 90th percentile distributions in each panel. P values were tested by Mann–Whitney U test. DM, diabetes; IS, indoxyl sulfate; T, thrombosis.

Comment in

Similar articles

Cited by

References

    1. National Kidney Foundation-Dialysis Outcomes Quality Initiative : NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 30[Suppl 3]: S150–S191, 1997 - PubMed
    1. US Renal Data System: USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010
    1. Roy-Chaudhury P, Sukhatme VP, Cheung AK: Hemodialysis vascular access dysfunction: A cellular and molecular viewpoint. J Am Soc Nephrol 17: 1112–1127, 2006 - PubMed
    1. Schwab SJ, Oliver MJ, Suhocki P, McCann R: Hemodialysis arteriovenous access: Detection of stenosis and response to treatment by vascular access blood flow. Kidney Int 59: 358–362, 2001 - PubMed
    1. Moist LM, Churchill DN, House AA, Millward SF, Elliott JE, Kribs SW, DeYoung WJ, Blythe L, Stitt LW, Lindsay RM: Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. J Am Soc Nephrol 14: 2645–2653, 2003 - PubMed

Publication types